Polyphosphate, Zn


Journal

Journal of thrombosis and haemostasis : JTH
ISSN: 1538-7836
Titre abrégé: J Thromb Haemost
Pays: England
ID NLM: 101170508

Informations de publication

Date de publication:
12 2019
Historique:
received: 23 05 2019
accepted: 09 08 2019
pubmed: 20 8 2019
medline: 9 9 2020
entrez: 18 8 2019
Statut: ppublish

Résumé

Inorganic polyphosphate modulates the contact pathway of blood clotting, which is implicated in thrombosis and inflammation. Polyphosphate polymer lengths are highly variable, with shorter polymers (approximately 60-100 phosphates) secreted from human platelets, and longer polymers (up to thousands of phosphates) in microbes. We previously reported that optimal triggering of clotting via the contact pathway requires very long polyphosphates, although the impact of shorter polyphosphate polymers on individual proteolytic reactions of the contact pathway was not interrogated. We conducted in vitro measurements of enzyme kinetics to investigate the ability of varying polyphosphate sizes, together with high molecular weight kininogen and Zn The individual contact pathway reactions were differentially dependent on polyphosphate length. Very long-chain polyphosphate was required to support factor XII autoactivation, whereas platelet-size polyphosphate significantly accelerated the activation of factor XII by kallikrein, and the activation of prekallikrein by factor XIIa. Intriguingly, polyphosphate did not support prekallikrein autoactivation. We also report that high molecular weight kininogen was required only when kallikrein was the enzyme (ie, FXII activation by kallikrein), whereas Zn Platelet polyphosphate and Zn

Sections du résumé

BACKGROUND
Inorganic polyphosphate modulates the contact pathway of blood clotting, which is implicated in thrombosis and inflammation. Polyphosphate polymer lengths are highly variable, with shorter polymers (approximately 60-100 phosphates) secreted from human platelets, and longer polymers (up to thousands of phosphates) in microbes. We previously reported that optimal triggering of clotting via the contact pathway requires very long polyphosphates, although the impact of shorter polyphosphate polymers on individual proteolytic reactions of the contact pathway was not interrogated.
OBJECTIVES AND METHODS
We conducted in vitro measurements of enzyme kinetics to investigate the ability of varying polyphosphate sizes, together with high molecular weight kininogen and Zn
RESULTS
The individual contact pathway reactions were differentially dependent on polyphosphate length. Very long-chain polyphosphate was required to support factor XII autoactivation, whereas platelet-size polyphosphate significantly accelerated the activation of factor XII by kallikrein, and the activation of prekallikrein by factor XIIa. Intriguingly, polyphosphate did not support prekallikrein autoactivation. We also report that high molecular weight kininogen was required only when kallikrein was the enzyme (ie, FXII activation by kallikrein), whereas Zn
CONCLUSIONS
Platelet polyphosphate and Zn

Identifiants

pubmed: 31420909
doi: 10.1111/jth.14612
pmc: PMC6893101
mid: NIHMS1056790
pii: S1538-7836(22)03092-6
doi:

Substances chimiques

Kininogen, High-Molecular-Weight 0
Polyphosphates 0
Factor Xa EC 3.4.21.6
Zinc J41CSQ7QDS

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2131-2140

Subventions

Organisme : NHLBI NIH HHS
ID : UM1 HL120877
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL058837
Pays : United States
Organisme : NHLBI NIH HHS
ID : R35 HL140025
Pays : United States
Organisme : NHLBI NIH HHS
ID : R35 HL135823
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL081326
Pays : United States

Informations de copyright

© 2019 International Society on Thrombosis and Haemostasis.

Références

Protein Sci. 1992 Jan;1(1):151-60
pubmed: 1304876
Blood. 2017 Mar 23;129(12):1707-1717
pubmed: 28049643
Eur J Biochem. 2001 Mar;268(6):1547-53
pubmed: 11248671
Thromb Res. 1980 Oct 15;20(2):163-71
pubmed: 6451948
Circ Res. 2016 Apr 29;118(9):1392-408
pubmed: 27126649
J Biol Chem. 1995 Aug 18;270(33):19256-61
pubmed: 7642598
J Biol Chem. 2004 Oct 22;279(43):44250-7
pubmed: 15308650
Blood. 2010 Nov 18;116(20):4353-9
pubmed: 20709905
Biol Proced Online. 2009 May 15;11:32-51
pubmed: 19495910
J Thromb Haemost. 2016 Jan;14(1):28-39
pubmed: 26565070
Proc Natl Acad Sci U S A. 2004 Nov 16;101(46):16085-7
pubmed: 15520374
Thromb Haemost. 2013 Mar;109(3):421-30
pubmed: 23306381
J Biol Chem. 1987 Aug 15;262(23):11308-14
pubmed: 2440889
Eur J Biochem. 2001 Jan;268(2):396-404
pubmed: 11168375
J Biol Chem. 1992 Sep 25;267(27):19691-7
pubmed: 1527088
J Cell Physiol. 1993 Sep;156(3):437-42
pubmed: 8360253
Blood. 2010 Nov 11;116(19):3981-9
pubmed: 20634381
J Clin Invest. 1955 Apr;34(4):602-13
pubmed: 14367514
Thromb Res. 1987 Oct 15;48(2):211-21
pubmed: 3501175
Int Immunopharmacol. 2008 Feb;8(2):155-60
pubmed: 18182219
J Biol Chem. 2017 Feb 3;292(5):1808-1814
pubmed: 28007958
Biochem J. 1982 Sep 1;205(3):529-34
pubmed: 6924583
J Exp Med. 2005 Jul 18;202(2):271-81
pubmed: 16009717
Int J Hematol. 2012 Apr;95(4):346-52
pubmed: 22477540
J Biol Chem. 1993 Jun 15;268(17):12477-83
pubmed: 8509387
Blood. 2017 Jul 6;130(1):88-91
pubmed: 28533308
Proc Natl Acad Sci U S A. 1978 Apr;75(4):1998-2002
pubmed: 273926
J Biol Chem. 1995 Mar 17;270(11):5818-22
pubmed: 7890711
Front Med (Lausanne). 2018 Jan 25;5:3
pubmed: 29423395
J Biol Chem. 2000 Oct 27;275(43):33814-9
pubmed: 10922361
Biochemistry. 1986 May 6;25(9):2410-7
pubmed: 3521732
Thromb Res. 2010 Mar;125(3):210-5
pubmed: 20022081
Thromb J. 2015 May 06;13:17
pubmed: 25949215
Eur J Biochem. 1997 Jan 15;243(1-2):160-6
pubmed: 9030735
J Exp Med. 2006 Mar 20;203(3):513-8
pubmed: 16533887
Thromb Haemost. 1991 Feb 12;65(2):117-21
pubmed: 1905067
Blood. 2011 Nov 10;118(19):5302-11
pubmed: 21821705
Proc Natl Acad Sci U S A. 2006 Jan 24;103(4):903-8
pubmed: 16410357
Thromb Res. 2016 Apr;140:118-124
pubmed: 26950760
J Thromb Haemost. 2016 Mar;14(3):427-37
pubmed: 26707513
PLoS One. 2012;7(11):e50399
pubmed: 23226277
Front Med (Lausanne). 2018 Apr 17;5:107
pubmed: 29719836
Thromb Haemost. 1979 Oct 31;42(3):1046-55
pubmed: 92069
Blood. 2017 Mar 16;129(11):1527-1537
pubmed: 28069606
Annu Rev Biochem. 1999;68:89-125
pubmed: 10872445
Blood. 2014 Mar 13;123(11):1739-46
pubmed: 24408325
Electrophoresis. 2007 Oct;28(19):3461-5
pubmed: 17847128
J Biol Chem. 1977 Sep 25;252(18):6432-7
pubmed: 893417
J Biol Chem. 2012 Aug 17;287(34):28435-44
pubmed: 22761438
Blood. 2004 Jun 15;103(12):4554-61
pubmed: 14996700
Trends Biochem Sci. 2008 Jun;33(6):284-90
pubmed: 18487048
FEBS Lett. 2002 Jul 17;523(1-3):167-70
pubmed: 12123826
J Thromb Haemost. 2010 Aug;8(8):1670-4
pubmed: 20456750

Auteurs

Yuqi Wang (Y)

Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor, MI, USA.

Ivan Ivanov (I)

Department of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.

Stephanie A Smith (SA)

Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor, MI, USA.

David Gailani (D)

Department of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

James H Morrissey (JH)

Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor, MI, USA.
Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH